26dems Homepage
Tech Advisory: This web page is best viewed in Firefox, Safari, or Internet Explorer version 7 and newer. You may have to upgrade Adobe Flashplayer if you experience problems. Report any problem to the webmaster.

Tuesday, August 25, 2009

Taking a Dump In Someone Else's Backyard: Six of the Ten Top U.S. Drug Companies Aren't American

Take a look at this well-sourced journal on Democratic Underground.

By McCamy Taylor

The U.S. pharmaceutical market, the world's biggest, rose 3.8 percent to $286.5 billion in 2007…


http://www.bloomberg.com/apps/news?pid=206...

That is a lot of money. It is almost a bank bailout every year. Of course, we know where this money is going. It is being recycled right back into the U.S. economy, unlike the cash that the banks refuse to loan. That is good for America, right? Even if our drugs are overpriced, and our pharmaceutical industry is waging a quiet war against healthcare reform, at least we can say that the dollars we spend on expensive designer copycat drugs like Nexium help pay for our roads and schools. And the companies that make them have a personal interest in seeing Americans and their communities prosper, because they are our neighbors….

There is just one problem with this rosy picture. It is not true.
Did you know that six out of the world’s top ten pharmaceutical companies are European owned? And even though they are headquartered in countries that boast of having the best healthcare systems in the world, these companies have no qualms about ripping off the American healthcare consumer. And interfering in our political process. Because, hey, money makes the world go round, and there is a lot of cash to be made from the wasteful, inefficient, expensive U.S. way of doing medicine.


Click here to read more to find out why it's easier for foreign drug companies Glaxcosmithkline,
Bayer, Hoffman-La Rouche, Sonofe-Aventis, Novartis, and AstraZeneca to gouge the American people on drug pricing.